ACR Image Metrix names Yi Zhu as new clinical research project manager

Published: 07/07

RESTON, VA, USA - (HealthTech Wire) - ACR Image Metrix, one of the nation’s top imaging contract research organizations, is pleased to announce the addition of Yi Zhu to its clinical research staff as clinical research project manager. Ms. Zhu is responsible for developing and reviewing all clinical study documentation, as well as managing site selection and coordination.

Ms. Zhu’s background includes years of experience in the healthcare industry, primarily focused on clinical research activities. Her clinical research experiences include clinical research project management, protocol development, IRB document preparation and submission, data management and analysis, and problem solving. Before joining ACR Image Metrix, Ms. Zhu led global trial initiation with Sanofi Aventis. She also served as the clinical research project coordinator with the A.I. DuPont Hospital for Children and was a clinical research associate with Thomas Jefferson University Hospital.

Ms. Zhu holds a Master of Business Administration degree from the University of Delaware in addition to a medical degree from the Chongqing University of Medical Science, P.R. China.

“We are pleased to have Yi join our staff. She will be based in Philadelphia and brings an immense amount of experience as a clinical research manager to Image Metrix,” said Mike Morales, vice president, general manager, ACR Image Metrix. “Her dedication to quality and efficiency in coordination with our various sites is instrumental to our clients’ success. Yi is also able to manage multiple projects effectively with great attention to detail.”

“The addition of Yi to our clinical research team is fundamental to our plans to extend our strong presence and growth within the scientific community,” said Dr. Bruce Hillman, chief scientific officer, ACR Image Metrix. “Research is critical to Image Metrix and Yi brings a deep understanding of the industry and how to communicate most effectively. It is a rare opportunity to welcome someone of Yi’s caliber and expertise.”